Endothelin Receptors and Their Antagonists
Open Access
- 1 March 2015
- journal article
- review article
- Published by Elsevier BV in Seminars in Nephrology
- Vol. 35 (2), 125-136
- https://doi.org/10.1016/j.semnephrol.2015.02.002
Abstract
No abstract availableKeywords
This publication has 85 references indexed in Scilit:
- Macitentan and Morbidity and Mortality in Pulmonary Arterial HypertensionNew England Journal of Medicine, 2013
- International Union of Basic and Clinical Pharmacology. LXXXVIII. G Protein-Coupled Receptor List: Recommendations for New Pairings with Cognate LigandsPharmacological Reviews, 2013
- Slow Receptor Dissociation Kinetics Differentiate Macitentan from Other Endothelin Receptor Antagonists in Pulmonary Arterial Smooth Muscle CellsPLOS ONE, 2012
- Macitentan: entry-into-humans study with a new endothelin receptor antagonistEuropean Journal of Clinical Pharmacology, 2011
- Avosentan for Overt Diabetic NephropathyJournal of the American Society of Nephrology, 2010
- Inhibition of endothelin receptors in the treatment of pulmonary arterial hypertension: does selectivity matter?European Heart Journal, 2008
- Collecting duct-specific knockout of the endothelin B receptor causes hypertension and sodium retentionAmerican Journal of Physiology-Renal Physiology, 2006
- Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptorLife Sciences, 1992
- A reversible radioligand specific for the ETB receptor: [125I]Tyr13-Suc-[Glu9,Ala11,15]-endothelin-1(8–21), [125I]IRL 1620Biochemical and Biophysical Research Communications, 1992
- Sarafotoxin S6c: An agonist which distinguishes between endothelin receptor subtypesBiochemical and Biophysical Research Communications, 1991